NCT06969079 Ba Duan Jin for CI With Hyperarousal/Anxiety
| NCT ID | NCT06969079 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xuanwu Hospital, Beijing |
| Condition | Mind-Body Therapies |
| Study Type | INTERVENTIONAL |
| Enrollment | 84 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2025-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 84 participants in total. It began in 2024-11-01 with a primary completion date of 2025-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled trial aims to evaluate the effectiveness of Ba Duan Jin exercise in treating chronic insomnia (CI) with comorbid hyperarousal and anxiety symptoms.
Eligibility Criteria
Inclusion Criteria: 1. Diagnosed with Insomnia Disorder according to DSM-5 criteria. 2. Pittsburgh Sleep Quality Index (PSQI) total score \> 5. 3. Age ≥ 8 years. 4. Educational level of at least junior high school. 5. Voluntarily agree to participate and sign informed consent. 6. Presence of anxiety symptoms, defined as a Hamilton Anxiety Rating Scale (HAMA-14) score ≥ 14. Exclusion Criteria: 1. Presence of severe physical illnesses or major psychiatric disorders, or assessed to be at risk of suicide. 2. Diagnosis or suspicion of sleep breathing disorder, restless legs syndrome, circadian rhythm sleep disorder, or engaged in night-shift work. 3. Pregnancy or breastfeeding. 4. Currently undergoing any form of psychological therapy.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06969079 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, studying Mind-Body Therapies. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06969079 currently recruiting?
Yes, NCT06969079 is actively recruiting participants. Contact the research team at wanghongxing@xwh.ccmu.edu.cn for enrollment information.
Where is the NCT06969079 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06969079 clinical trial?
NCT06969079 is sponsored by Xuanwu Hospital, Beijing. The trial plans to enroll 84 participants.